Segmentation based on physician behavior: Implications for sales forecasting and marketing-mix strategy

Journal of Personal Selling and Sales Management

Volumn 29, Issue 1, 2009, Pages 81-95

  Carter, Franklin ^a   Chitturi, Ravindra ^b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b LEHIGH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649522312     PISSN: 08853134     EISSN: None     Source Type: Journal    
DOI: 10.2753/PSS0885-3134290105     Document Type: Article

References (36)

1. Akaike, Hirotsugu (1974), "A New Look at the Statistical Model Identifi cation," IEEE Transactions on Automatic Control, 19 (6), 716-723.
2. Azoulay, Pierre (2002), "Do Pharmaceutical Sales Respond to Scientifi c Evidence?" Journal of Economics and Management Strategy, 11 (4), 551-594.
3. Bass, Frank (1969), "A New Product Growth Model for Consumer Durables," Management Science, 15 (January), 215-227.
4. - , Trichy V. Krishnan, and Dipak C. Jain (1994), "Why the Bass Model Fits Without Marketing Mix Variables," Marketing Science, 13 (3), 203-223.
5. Berndt, Ernst R., Linda Bui, David R. Reiley, and Glen Urban (1995), "Information, Marketing, and Pricing in the U.S. Antiulcer Drug Market," American Economic Review, 85 (2), 100-105.
6. Carter, Franklin J., Carol Motley, Alphonso Ogbuehi, and Jacqueline A. Williams (2006), "An Application of a Repeat-Purchase Diffusion Model to the Pharmaceutical Industry," Advances in Business and Management Forecasting, 4 (February), 145-174.
7. Cleary, John D. (1992), "Impact of Pharmaceutical Sales Representatives on Physician Antibiotic Prescribing," Journal of Pharmacy Technology, 8 (5), 27-29.
8. Corrigan, Mark H., and Harold E. Glass (2005), "Physician Participation in Clinical Studies and Subsequent Prescribing of New Drugs," Pharmacy and Therapeutics, 30 (1), 60-66.
9. Desiraju, Ramarao, Harikesh Nair, and Pradeep Chintagunta (2004), "Diffusion of New Pharmaceutical Drugs in Developing and Developed Nations," International Journal of Research in Marketing, 21 (4), 341-357.
10. Durbin, John (1970), "Testing for Serial Correlation in Least-Squares Regression When Some of the Regressors are Lagged Dependent Variables," Econometrica, 38 (3), 410-421.
11. Easingwood, Christopher J., Vijay Mahajan, and Eitan Muller (1983), "A Non-Uniform Infl uence Innovation Diffusion Model of New Product Acceptance," Management Science, 2 (3), 273-296.
12. Freeman, Robert, and Senyo Tse (1992),"A Nonlinear Model of Security Price Responses to Unexpected Earnings," Journal of Accounting Research, 30 (2), 185-209.
13. Gatignon, Hubert, Barton Weitz, and Pradeep Bansal (1990), "Introduction Strategies and Competitive Environments," Journal of Marketing Research, 27 (4), 390-401.
14. Glass, Harold E., and Bruce Rosenthal (2004), "Demographics, Practices, and Prescribing Characteristics of Physicians Who Are Early Adopters of New Drugs" Pharmacy and Therapeutics, 29 (1), 699-708.
15. Gönül, Fusun, Franklin Carter, Elina Petrova, and Kannan Srinivasan (2001), "Promotion of Prescription Drugs and Its Impact on Physicians' Choice Behavior," Journal of Marketing, 65 (7), 79-90.
16. Hahn, Minhi, Schoon Park, Lakshman Krishnamurthi, and Andris Zoltners (1994), "Analysis of New Product Diffusion Using a Four-Segment Trial-Repeat Model," Marketing Science, 14 (3), 224-247.
17. Iizuka, Toshiaki, and Ginger Z. Jin (2003), "The Effects of Direct-to-Consumer Advertising in the Prescription Drug Markets" Owen Graduate School of Management, Vander-bilt University, and Department of Economics, University of Maryland (available at www.astrazenecaus.com/content/ aboutAZ/healthIssuesPerspectives/dtcLinks/iizuka.pdf ).
18. IMS Health (2007), "IMS National Sales Perspectives," Nor-walk, CT (available at www1.imshealth.com/ims/portal/ front/articleC/0,2777,6599- 40868211-40868264,00 .html#ims).
19. Leefl ang, Peter, Gregory Mijatovic, and John Saunders (1992), "Identifi cation and Estimation of Complex Multivariate Lag Structures: A Nesting Approach," Applied Economics, 24 (2), 273-281.
20. Lilien, Gary, Ambar Rao, and Shlomo Kalish (1981), "Baysian Estimation and Control of Detailing Effort in a Repeat Purchase Diffusion Environment," Management Science, 27 (May), 493-506.
21. Mahajan, Vijay, and Eitan Muller (1982), "Innovation Behavior and Repeat Purchase Diffusion Model," in Proceedings of the American Marketing Association Educators Conference, Series 48, Chicago: American Marketing Association, 456-460.
22. - , Yoram Wind, and Subdash Sharma (1983), "An Approach to Repeat-Purchase Diffusion Analysis," in Proceedings of the American Marketing Association Educators Conference, Series 49, Patrick Murphy et al., eds., Chicago: American Marketing Association, 442-446.
23. Manchanda, Puneet, and Pradeep K. Chintagunta (2004), "Responsiveness of Physician Prescription Behavior to Sales Force Effort: An Individual Level Analysis," Marketing Letters, 15 (2-3), 129-145.
24. - , Peter Rossi, and Pradeep Chintagunta (2004), "Response Modeling with Non-Random Marketing Mix Variables," Journal of Marketing Research, 41 (November), 467-478.
25. McGuire , Stephen (2007), "Force in the Field," Medical Marketing and Media, 42 (November), 39-45.
26. Mizik, Natalie, and Robert Jacobson (2004), "Are Physicians Easy Marks? Quantifying the Effects of Detailing and Sampling on New Prescriptions," Management Science, 50 (12), 1702-1715.
27. Narayanan, Sridhar, Puneet Manchanda, and Pradeep Chin-tagunta (2005), "Temporal Differences in the Role of Marketing Communication for New Products," Journal of Marketing Research, 42 (3), 278-291.
28. Nickum, Chris (2007), "Optimal Sales Force Efforts in Specialty Care Markets: New, More Precise Measures Increase Sales Force Effectiveness," IMS Health, Norwalk, CT (available at www.imshealth.com/deployedfi les/imshealth/Global/ Content/StaticFile/Optimizing-Sales-Efforts.pdf).
29. Parsons, Leonard J., and Piet Vanden Abeele (1981), "Analysis of Sales Call Effectiveness," Journal of Marketing Research, 18 (February), 107-113.
30. Rao, Ambar, and Masataka Yamada (1988), "Forecasting with a Repeat Purchase Diffusion Model," Management Science, 4 (June), 734-752.
31. Ratchford, Brian, Siva Balasubramanian, and Wagner Kamakura (2000), "Diffusion Models with Replacement and Multiple Purchases," in International Series in Quantitative Marketing: New-Product Diffusion Models, Vijay Mahajan, Eitan Muller, and Yoram Wind, eds., New York: Kluwer Academic, 123-140.
32. Ruiz-Conde, Enar, Jaap Wieringa, and Peter Leefl ang (2006), "Longitudinal and Cross-Sectional Effects of Marketing Instruments on Diffusion of Pharmaceuticals," Working Paper, University of Groningen.
33. Stine, Robert A. (1995), "Graphical Interpretation of Variance Infl ation Factors," American Statistician, 49 (1), 53-56.
34. Van den Bulte, Christophe, and Yogesh Joshi (2007), "New Product Diffusion with Infl uentials and Imitators," Marketing Science, 26 (3), 400-421.
35. Weintraub, Arlene (2007), "The Doctor Won't See You Now," Business Week (February 5), 30-32.
36. Wittink, Dick R., and George Clark (2002), "Analysis of ROI for Pharmaceutical Promotion (ARPP)," Yale School of Management (available at www.rxpromoroi.org/arpp/ media/arpp-handout-0927.pdf).